DNM1 and cancer: By adjusting for confounders with GEE, cancer patients without PCD, on average, were found with higher DNM1 levels post-baseline compared to non-cancer counterparts (RC ​= ​2.04, 95 ​% CI ​= ​1.51 to 2.77, P ​< ​0.001, Table S1).